- Home
- CHEK vs PAVM Comparison
CHEK vs PAVM Comparison
Compare CHEK & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- PAVM
- Stock Information
- Founded
- CHEK 2004
- PAVM 2014
- Country
- CHEK Israel
- PAVM United States
- Employees
- CHEK N/A
- PAVM N/A
- Industry
- CHEK Medical Electronics
- PAVM Medical/Dental Instruments
- Sector
- CHEK Health Care
- PAVM Health Care
- Exchange
- CHEK Nasdaq
- PAVM Nasdaq
- Market Cap
- CHEK 4.4M
- PAVM 12.0M
- IPO Year
- CHEK 2015
- PAVM 2016
- Fundamental
- Price
- CHEK N/A
- PAVM $0.60
- Analyst Decision
- CHEK
- PAVM Strong Buy
- Analyst Count
- CHEK 0
- PAVM 1
- Target Price
- CHEK N/A
- PAVM $19.00
- AVG Volume (30 Days)
- CHEK 28.3K
- PAVM 149.7K
- Earning Date
- CHEK 08-14-2025
- PAVM 08-11-2025
- Dividend Yield
- CHEK N/A
- PAVM N/A
- EPS Growth
- CHEK N/A
- PAVM N/A
- EPS
- CHEK N/A
- PAVM 0.96
- Revenue
- CHEK N/A
- PAVM $1,993,000.00
- Revenue This Year
- CHEK N/A
- PAVM N/A
- Revenue Next Year
- CHEK N/A
- PAVM $455.63
- P/E Ratio
- CHEK N/A
- PAVM $0.62
- Revenue Growth
- CHEK N/A
- PAVM N/A
- 52 Week Low
- CHEK $0.56
- PAVM $0.55
- 52 Week High
- CHEK $3.04
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- CHEK 41.81
- PAVM 42.72
- Support Level
- CHEK $0.75
- PAVM $0.57
- Resistance Level
- CHEK $0.86
- PAVM $0.62
- Average True Range (ATR)
- CHEK 0.03
- PAVM 0.04
- MACD
- CHEK 0.00
- PAVM -0.00
- Stochastic Oscillator
- CHEK 19.59
- PAVM 23.46
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.